Discovery & Development Europe 2026
15-16 June 2026 | Berlin
Magnus Ivarsson, Chief Scientific Officer
“Modulating Sleep As An Entry Point To Treating Neurodegenerative Disorders” presentation
Tuesday 16 June 2026, 09:25-09:50 CEST
Magnus Ivarsson, Chief Scientific Officer
“Modulating Sleep As An Entry Point To Treating Neurodegenerative Disorders” presentation
Tuesday 16 June 2026, 09:25-09:50 CEST
Michelle Mellion, Chief Medical Officer and Deb Gouveia, VP, Clinical Operations and Development Strategy attending event
Jane Rhodes, Chief Executive Officer
Presentation: Wednesday 24 June, 14:00-14:15 PDT, Theater 4
Jane Rhodes, Chief Executive Officer attending event
There are currently no past events.